Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> China Pharma Providers
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
China Pharma Providers
Type:
CRO-Discovery
Title:
Shenzhen Chipsceen Biosciences Ltd
Chinese
CSertification:
n/a
International
Certification:
n/a
Primary Location:
Shenzhen
China
Contact Info:
n/a
Webpage:
www.chipscreen.com
HQ
Contact Info:
Suite C301-309, P.O. Box 28, Research Institute of Tsinghua University, High-Tech Industrial Park, Nanshan District, Shenzhen, Guangdong 518057, China
Tel: +86 755 2695 7317; 26957730 Fax: +86 755 26957291
Email: info@Chipscreen.com
Additional
Contact Info:
n/a
Description:
Chipscreen is currently the leader in proprietary drug discovery and development focusing on small molecule therapeutics in China where the country is emerging as the fifth largest pharmaceutical markets worldwide. Chipscreen is uniquely positioning as the only few biotech or pharma companies in China having experience and expertise to engage in innovative research and develops proprietary medicine product in China where over 97% of the industry are generic companies. As a China-based biotech of 6-year old, it has achieved several milestones that make Chipscreen clearly the leader in innovative drug discovery and development in China. The company differs most from other biotech in China today is its science-driven approach in discovery, strong pipeline building capability, very experience with IP, and regulatory expertise. Currently, its several proprietary products in clinical trial development and out-licensed candidates are the best evidence.
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit